GSK | ||
|---|---|---|
OUTLOOK RATING 1..100 | 76 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 5 Undervalued | |
PROFIT vs RISK RATING 1..100 | 51 | |
SMR RATING 1..100 | 34 | |
PRICE GROWTH RATING 1..100 | 58 | |
P/E GROWTH RATING 1..100 | 65 | |
SEASONALITY SCORE 1..100 | 50 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
| EUDG | GSK | |
|---|---|---|
| RSI ODDS (%) | 2 days ago 88% | N/A |
| Stochastic ODDS (%) | 2 days ago 85% | 2 days ago 64% |
| Momentum ODDS (%) | 2 days ago 70% | 2 days ago 46% |
| MACD ODDS (%) | 2 days ago 78% | 2 days ago 55% |
| TrendWeek ODDS (%) | 2 days ago 75% | 2 days ago 53% |
| TrendMonth ODDS (%) | 2 days ago 72% | 2 days ago 51% |
| Advances ODDS (%) | 10 days ago 80% | 26 days ago 63% |
| Declines ODDS (%) | 3 days ago 75% | 5 days ago 54% |
| BollingerBands ODDS (%) | 2 days ago 85% | 2 days ago 70% |
| Aroon ODDS (%) | 2 days ago 77% | 2 days ago 43% |
A.I.dvisor tells us that EUDG and FOUR have been poorly correlated (+21% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that EUDG and FOUR's prices will move in lockstep.
| Ticker / NAME | Correlation To EUDG | 1D Price Change % | ||
|---|---|---|---|---|
| EUDG | 100% | +0.39% | ||
| FOUR - EUDG | 21% Poorly correlated | +4.69% | ||
| NEM - EUDG | 18% Poorly correlated | +0.53% | ||
| OR - EUDG | 18% Poorly correlated | +0.53% | ||
| MC - EUDG | 14% Poorly correlated | -0.34% | ||
| GSK - EUDG | 14% Poorly correlated | +0.02% | ||
More | ||||
A.I.dvisor indicates that over the last year, GSK has been loosely correlated with NVS. These tickers have moved in lockstep 64% of the time. This A.I.-generated data suggests there is some statistical probability that if GSK jumps, then NVS could also see price increases.